Example #1: In connection with this Annual Report of Beauty Brands Group, Inc. (the “ Company ”) on Form 10-K for the year ending December 31, 2009, as filed with the Securities and Exchange Commission on the date hereof (the “ Report ”), I, James Altucher, Chairman of the Board of Directors and President of the Company, certify to the best of my knowledge, pursuant to 18 U.S.C. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:
Expected output: 'entities: [{'span': 'Beauty Brands Group, Inc.', 'entity': 'Business'}, {'span': 'Form 10-K', 'entity': 'Miscellaneous'}, {'span': 'James Altucher', 'entity': 'Person'}, {'span': 'U.S.C.', 'entity': 'Legislation/Act'}, {'span': 'Sarbanes-Oxley Act of 2002', 'entity': 'Legislation/Act'}]'

Example #2: In connection with this Annual Report of Beauty Brands Group, Inc. (the “ Company ”) on Form 10-K for the year ending December 31, 2009, as filed with the Securities and Exchange Commission on the date hereof (the “ Report ”), I, Dan Kelly, Directors and Chief Financial Officer of the Company, certify to the best of my knowledge, pursuant to 18 U.S.C. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:
Expected output: 'entities: [{'span': 'Beauty Brands Group, Inc.', 'entity': 'Business'}, {'span': 'Form 10-K', 'entity': 'Miscellaneous'}, {'span': 'Dan Kelly', 'entity': 'Person'}, {'span': 'U.S.C.', 'entity': 'Legislation/Act'}, {'span': 'Sarbanes-Oxley Act of 2002', 'entity': 'Legislation/Act'}]'

Example #3: To vote by telephone, please call the toll-free number located on your proxy card and follow the recorded instructions, using your proxy card as a guide.
Expected output: 'entities: []'

Example #4: The cost of preparing, printing and mailing the enclosed proxy, accompanying notice and proxy statement and all other costs in connection with the solicitation of proxies will be paid by the Funds pro rata based on the number of shareholder accounts.
Expected output: 'entities: []'

Example #5: For purposes of determining the approval of the proposal to elect nominees for each Fund, abstentions and broker non-votes will have no effect on the election of Board Members.
Expected output: 'entities: []'

Example #6: Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized in the City of Seattle, State of Washington, on April 1, 2011.
Expected output: 'entities: [{'span': 'Securities Act of 1933', 'entity': 'Legislation/Act'}, {'span': 'Form S-3', 'entity': 'Miscellaneous'}, {'span': 'City of Seattle', 'entity': 'Location'}, {'span': 'State of Washington', 'entity': 'Location'}]'

Example #7: Morgan Securities executed on June 17, 2011, a Consent of Defendant J.P. Morgan Securities (the “ Consent ”), in which J.P. Morgan Securities neither admitted nor denied any of the allegations (except as to personal and subject matter jurisdiction) in a complaint filed by the Commission, but in which it consented to the entry of a final judgment (“ Final Judgment ”) against it by the United States District Court for the Southern District of New York (the “ Court ”).
Expected output: 'entities: [{'span': 'Morgan Securities', 'entity': 'Business'}, {'span': 'J.P. Morgan Securities', 'entity': 'Business'}, {'span': 'United States District Court for the Southern District of New York', 'entity': 'Court'}]'

Example #8: This Information Statement has been filed with the Securities and Exchange Commission and is being furnished, pursuant to Section 14C of the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), to the holders (the “ Stockholders ”) of the common stock, par value $ .0001 per share (the “ Common Stock ”), of Comcam, Inc., a Delaware Corporation (the “ Company ”), to notify such Stockholders that on or about March 5, 2010, the Company received written consents in lieu of a meeting of Stockholders from holders of 683,952,500 shares representing approximately 91 % of the 744,640,134 shares of the total issued and outstanding shares of voting stock of the Company (the “ Majority Stockholders ”) to authorize 1-for-85 reverse stock split (pro-rata reduction of outstanding shares) of our issued and outstanding shares of Common Stock (the “ Reverse Stock Split ”).
Expected output: 'entities: [{'span': 'Securities and Exchange Commission', 'entity': 'Government'}, {'span': 'Securities Exchange Act of 1934', 'entity': 'Legislation/Act'}, {'span': 'Exchange Act', 'entity': 'Legislation/Act'}, {'span': 'Comcam, Inc.', 'entity': 'Business'}, {'span': 'Delaware', 'entity': 'Location'}]'

Example #9: Shareholders of record at the close of business on February 8, 2010 are entitled to notice of and to vote at the Annual Meeting.
Expected output: 'entities: []'

Example #10: For each other Massachusetts Business Trust except New York Value 2, Core Equity, Equity Premium, Equity Premium Advantage, Equity Premium Income, Equity Premium Opportunity, Global Government, Global Value, Tax-Advantaged Dividend and Multi-Currency, New York Dividend, New York Dividend 2, Insured New York Dividend and Insured New York Tax-Free, Board Members Amboian, Kundert and Toth were last elected to each Fund s Board as Class II Board Members at the annual meeting of shareholders held on June 30, 2008.
Expected output: 'entities: [{'span': 'Massachusetts', 'entity': 'Location'}, {'span': 'New York Value 2', 'entity': 'Business'}, {'span': 'Core Equity', 'entity': 'Business'}, {'span': 'Equity Premium', 'entity': 'Business'}, {'span': 'Equity Premium Advantage', 'entity': 'Business'}, {'span': 'Equity Premium Income', 'entity': 'Business'}, {'span': 'Equity Premium Opportunity', 'entity': 'Business'}, {'span': 'Global Government', 'entity': 'Business'}, {'span': 'Global Value', 'entity': 'Business'}, {'span': 'Tax-Advantaged Dividend', 'entity': 'Business'}, {'span': 'Multi-Currency', 'entity': 'Business'}, {'span': 'New York Dividend', 'entity': 'Business'}, {'span': 'New York Dividend 2', 'entity': 'Business'}, {'span': 'Insured New York Dividend', 'entity': 'Business'}, {'span': 'Insured New York Tax-Free', 'entity': 'Business'}, {'span': 'Amboian', 'entity': 'Person'}, {'span': 'Kundert', 'entity': 'Person'}, {'span': 'Toth', 'entity': 'Person'}]'

Example #11: Except for the Funds, Audit Committee members shall not serve simultaneously on the audit committees of more than two other public companies.
Expected output: 'entities: []'

Example #12: Board Members Amboian, Kundert and Toth were last elected as Class II Board Members at the annual meeting of shareholders held on June 30, 2008.
Expected output: 'entities: [{'span': 'Amboian', 'entity': 'Person'}, {'span': 'Kundert', 'entity': 'Person'}, {'span': 'Toth', 'entity': 'Person'}]'

Example #13: Those persons who were shareholders of record at the close of business on Monday, February 8, 2010 will be entitled to one vote for each share held and a proportionate fractional vote for each fractional vote held.
Expected output: 'entities: []'

Example #14: We, the undersigned directors of Acorda Therapeutics, Inc., hereby severally constitute and appoint Ron Cohen our true and lawful attorney with full power to him to sign for us and in our names in the capacities indicated below, this Registration Statement on Form S-8 filed herewith and any and all subsequent amendments to said registration statement, and generally to do all such things in our names and on our behalf in our capacities as directors to enable Acorda Therapeutics, Inc. to comply with the provisions of the Securities Act of 1933, as amended, and all requirements of the Securities and Exchange Commission, hereby ratifying and confirming our signatures as they may be signed by our said attorney to said registration statement and any and all amendments thereto.
Expected output: 'entities: [{'span': 'Acorda Therapeutics, Inc.', 'entity': 'Business'}, {'span': 'Ron Cohen', 'entity': 'Person'}, {'span': 'Form S-8', 'entity': 'Miscellaneous'}, {'span': 'Securities Act of 1933', 'entity': 'Legislation/Act'}, {'span': 'Securities and Exchange Commission', 'entity': 'Government'}]'

Example #15: Under each Fund s By-Laws, an adjournment of a meeting with respect to a matter requires the affirmative vote of a majority of the shares entitled to vote on the matter present in person or represented by proxy at the meeting.
Expected output: 'entities: []'

Example #16: Board Members Amboian, Kundert and Toth were last elected to each Fund s Board as Class II Board Members and Board Member Hunter was last elected to each Fund s Board as a Class I Board Member at the annual meeting of shareholders held on June 30, 2008.
Expected output: 'entities: [{'span': 'Amboian', 'entity': 'Person'}, {'span': 'Kundert', 'entity': 'Person'}, {'span': 'Toth', 'entity': 'Person'}, {'span': 'Hunter', 'entity': 'Person'}]'

Example #17: The inspectors of election will treat abstentions and broker non-votes (i.e., shares held by brokers or nominees, typically in street name, as to which (i) instructions have not been received from the beneficial owners or persons entitled to vote and (ii) the broker or nominee does not have discretionary voting power on a particular matter) as present for purposes of determining a quorum.
Expected output: 'entities: []'

Example #18: The undersigned hereby makes, constitutes and appoints each of Michael J. Berner and Douglas W. Ambrose as the undersigned ’ s true and lawful authorized representative, attorney-in-fact and agent, each with the power individually to execute for and on behalf of the undersigned and to file with and deliver to the United States Securities and Exchange Commission and any other authority or party required or entitled to receive the same: (a) any Forms 3, 4 and 5, and any amendments thereto, in accordance with Section 16 (a) of the Securities Exchange Act of 1934, as amended (the “ 1934 Act ”), and the rules promulgated thereunder; and (b) any Schedule 13D or Schedule 13G, and any amendments thereto, on behalf of the undersigned in accordance with Section 13 of the 1934 Act and the rules promulgated thereunder.
Expected output: 'entities: [{'span': 'Michael J. Berner', 'entity': 'Person'}, {'span': 'Douglas W. Ambrose', 'entity': 'Person'}, {'span': 'United States Securities and Exchange Commission', 'entity': 'Government'}, {'span': 'Forms 3, 4 and 5', 'entity': 'Miscellaneous'}, {'span': 'Securities Exchange Act of 1934', 'entity': 'Legislation/Act'}, {'span': '1934 Act', 'entity': 'Legislation/Act'}, {'span': 'Schedule 13D', 'entity': 'Miscellaneous'}, {'span': 'Schedule 13G', 'entity': 'Miscellaneous'}]'

Example #19: Based on the committee s review and discussions with management and the independent registered public accounting firm, the representations of management and the report of the independent registered public accounting firm to the committee, the committee has recommended that the audited financial statements be included in each Fund s Annual Report.
Expected output: 'entities: []'

Example #20: The Company is subject to the informational requirements of the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), and in accordance therewith files reports, proxy statements and other information including annual and quarterly reports on Form 10-K and 10-Q (the “ 1934 Act Filings ”) with the Securities and Exchange Commission (the “ Commission ”).
Expected output: 'entities: [{'span': 'Securities Exchange Act of 1934', 'entity': 'Legislation/Act'}, {'span': 'Exchange Act', 'entity': 'Legislation/Act'}, {'span': 'Form 10-K', 'entity': 'Miscellaneous'}, {'span': '10-Q', 'entity': 'Miscellaneous'}, {'span': '1934 Act Filings', 'entity': 'Miscellaneous'}, {'span': 'Securities and Exchange Commission', 'entity': 'Government'}]'

